世界の経皮的血管形成術用バルーン市場:医療機器パイプライン分析2016

◆英語タイトル:Percutaneous Transluminal Angioplasty Balloons - Medical Devices Pipeline Assessment, 2016
◆商品コード:GDME0196EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年6月1日
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥555,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥832,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、経皮的血管形成術用バルーンのグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。
・経皮的血管形成術用バルーンの概要
・経皮的血管形成術用バルーンの開発動向:開発段階別分析
・経皮的血管形成術用バルーンの開発動向:セグメント別分析
・経皮的血管形成術用バルーンの開発動向:領域別分析
・経皮的血管形成術用バルーンの開発動向:規制Path別分析
・経皮的血管形成術用バルーンの開発動向:承認日(推定)別分析
・企業別経皮的血管形成術用バルーンの開発動向(パイプライン製品、進行中の治験)
・経皮的血管形成術用バルーンの最近動向
【レポートの概要】

Percutaneous Transluminal Angioplasty Balloons – Medical Devices Pipeline Assessment, 2016

Summary

GlobalData’s Medical Devices sector report, “Percutaneous Transluminal Angioplasty Balloons – Medical Devices Pipeline Assessment, 2016″ provides an overview of Percutaneous Transluminal Angioplasty Balloons currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Angioplasty Balloons pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Percutaneous Transluminal Angioplasty Balloons under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Percutaneous Transluminal Angioplasty Balloons and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Percutaneous Transluminal Angioplasty Balloons under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Percutaneous Transluminal Angioplasty Balloons Overview 6
3 Products under Development 7
3.1 Percutaneous Transluminal Angioplasty Balloons – Pipeline Products by Stage of Development 7
3.2 Percutaneous Transluminal Angioplasty Balloons – Pipeline Products by Territory 8
3.3 Percutaneous Transluminal Angioplasty Balloons – Pipeline Products by Regulatory Path 9
3.4 Percutaneous Transluminal Angioplasty Balloons – Pipeline Products by Estimated Approval Date 10
3.5 Percutaneous Transluminal Angioplasty Balloons – Ongoing Clinical Trials 11
4 Percutaneous Transluminal Angioplasty Balloons – Pipeline Products under Development by Companies 12
4.1 Percutaneous Transluminal Angioplasty Balloons Companies – Pipeline Products by Stage of Development 12
4.2 Percutaneous Transluminal Angioplasty Balloons – Pipeline Products by Stage of Development 13
5 Percutaneous Transluminal Angioplasty Balloons Companies and Product Overview 14
5.1 Andramed GmbH Company Overview 14
5.1.1 Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Arravasc Limited Company Overview 16
5.2.1 Arravasc Limited Pipeline Products & Ongoing Clinical Trials Overview 16
5.3 Boston Scientific Corporation Company Overview 18
5.3.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 18
5.4 Contego Medical, LLC Company Overview 20
5.4.1 Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 20
5.5 MicroPort Scientific Corporation Company Overview 24
5.5.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 24
5.6 Occlutech International AB Company Overview 27
5.6.1 Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 QT Vascular Ltd. Company Overview 29
5.7.1 QT Vascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 29
5.8 SurModics, Inc. Company Overview 33
5.8.1 SurModics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
5.9 Terumo Corporation Company Overview 37
5.9.1 Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview 37
6 Percutaneous Transluminal Angioplasty Balloons- Recent Developments 39
6.1 May 11, 2016: Teleflex Raises USD400 Million in Public Offering of 4.875% Notes Due 2026 39
6.2 Apr 21, 2016: AV Medical Announces Successful Completion of 30 Patient Study with its Innovative Angioplasty Balloon Catheter, Chameleon 39
6.3 Apr 13, 2016: STENTYS Reports 38% Increase in Revenues in First Quarter 2016 40
6.4 Mar 16, 2016: STENTYS Reports 2015 Annual Results 40
6.5 Feb 19, 2016: Nipro Medical Corporation launches the Cronus HP 0.035″ OTW PTA Balloon Catheter in the United States 41
6.6 Feb 12, 2016: Stentys Raises USD14.3 Million in Rights Offering of Shares 41
6.7 Feb 09, 2016: New Real-World Comparison Showing Similar Efficacy Between the Lutonix and In.Pact Drug-Coated Balloons Featured at LINC 2016 42
6.8 Jan 26, 2016: Contego Medical Announces Positive Clinical Data for Paladin System, the First Post-Dilation Balloon with Integrated Embolic Protection Technology 43
6.9 Jan 13, 2016: STENTYS Reports 81% Year-over-Year Growth in Fourth-Quarter 2015 Revenues 43
6.10 Jan 11, 2016: SurModics Acquires NorMedix for USD14 Million 44
6.11 Jan 04, 2016: NuCryo Vascular Gets FDA 510(k) Approval For Next-generation Cryoplasty Inflation Device 44
6.12 Dec 28, 2015: Registration of Dongguan Kewei Occluder Series Products in Kazakhstan Approved 44
6.13 Dec 23, 2015: MicroPort Completed the First Distant Interactive Surgery in the Field of Coronary Interventional Treatment 45
6.14 Dec 02, 2015: MicroPort Orthopedics Attend the Tenth Session of the COA International Conference 45
6.15 Nov 03, 2015: Additional First Time Endovascular Clinical Trial Results Announced At VIVA15 47
6.16 Oct 15, 2015: STENTYS Reports 84% Growth in Third-Quarter 2015 Revenues 48
6.17 Oct 12, 2015: Lutonix Global Real-World Registry Outcomes Presented at TCT 2015 48
6.18 Sep 30, 2015: QT Vascular Announces Positive Outcome in Spectranetics/AngioScore Patent Trial 49
6.19 Sep 17, 2015: STENTYS Reports First Half 2015 Financial Results 49
6.20 Sep 09, 2015: MicroPort Scientific Corporation Announce Leadership Changes in MicroPort Orthopedics Subsidiary and Membership Changes in CEC, IEC 49
6.21 Sep 01, 2015: MPSC New COO Appointment – Jason Zhang 51
6.22 Aug 31, 2015: Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 51
6.23 Aug 03, 2015: CMS Approves Add-on Payment for Lutonix Drug-Coated Balloon for Inpatient Use 52
6.24 Jul 14, 2015: QT Vascular Announces The Allowance Of Four New Patents 52
6.25 Jul 08, 2015: QT Vascular – AngioScore Litigation Additional Updates 53
6.26 Jul 08, 2015: STENTYS Reports 40% Increase in Revenues in Second Quarter of 2015 55
6.27 Jun 24, 2015: Spectranetics Receives FDA 510(k) Clearance for Larger Diameter AngioSculpt Scoring Balloon Enabling Entry Into New Markets 56
6.28 Jun 24, 2015: Premier showcases medical innovations designed to improve patient care 56
6.29 Jun 02, 2015: Re-inflating balloon after carotid stenting appears to double risk of stroke and death 57
7 Appendix 59
7.1 Methodology 59
7.2 About GlobalData 61
7.3 Contact Us 62
7.4 Disclaimer 62

1.1 List of Tables
Table 1: Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Stage of Development 7
Table 2: Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Territory 8
Table 3: Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Regulatory Path 9
Table 4: Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Estimated Approval Date 10
Table 5: Percutaneous Transluminal Angioplasty Balloons - Ongoing Clinical Trials 11
Table 6: Percutaneous Transluminal Angioplasty Balloons Companies - Pipeline Products by Stage of Development 12
Table 7: Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Stage of Development 13
Table 8: Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 14
Table 9: Zero-Profile PTA Balloon - Product Status 14
Table 10: Zero-Profile PTA Balloon - Product Description 15
Table 11: Arravasc Limited Pipeline Products & Ongoing Clinical Trials Overview 16
Table 12: Pirouette 014 PTA Catheter - Product Status 16
Table 13: Pirouette 014 PTA Catheter - Product Description 17
Table 14: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 18
Table 15: Next Generation 0.018” Balloon - Product Status 18
Table 16: Next Generation 0.018” Balloon - Product Description 19
Table 17: Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 20
Table 18: PALADIN - Product Status 20
Table 19: PALADIN - Product Description 20
Table 20: Superficial Femoral Artery Balloon - Product Status 21
Table 21: Superficial Femoral Artery Balloon - Product Description 21
Table 22: Contego Medical, LLC - Ongoing Clinical Trials Overview 22
Table 23: PALADIN - Multi-center Study to Evaluate Acute Safety and Clinical Performance of Paladin Carotid Post-dilation Balloon with Integrated Embolic Protection 23
Table 24: MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 24
Table 25: Reewarm14 - Product Status 24
Table 26: Reewarm14 - Product Description 25
Table 27: Reewarm18 Peripheral Balloon Dilation Catheter - Product Status 25
Table 28: Reewarm18 Peripheral Balloon Dilation Catheter - Product Description 26
Table 29: Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview 27
Table 30: Occlutech Sizing Balloon - Product Status 27
Table 31: Occlutech Sizing Balloon - Product Description 28
Table 32: QT Vascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 29
Table 33: Chocolate PTA Balloon Catheter - Product Status 29
Table 34: Chocolate PTA Balloon Catheter - Product Description 30
Table 35: QT Vascular Ltd. - Ongoing Clinical Trials Overview 31
Table 36: Chocolate PTA Balloon Catheter - Chocolate Balloon Angioplasty Registry (Chocolate BAR) 32
Table 37: Chocolate PTA Balloon Catheter - Procedural Success Assessment After Treatment With Drug Coated Chocolate Balloon 32
Table 38: SurModics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
Table 39: 0.018” OTW Dual Lumen PTA Catheter - Product Status 33
Table 40: 0.018” OTW Dual Lumen PTA Catheter - Product Description 34
Table 41: 0.018” RX Dual Lumen PTA Catheter - Product Status 34
Table 42: 0.018” RX Dual Lumen PTA Catheter - Product Description 34
Table 43: 0.035” Large Diameter OTW PTA Catheter - Product Status 35
Table 44: 0.035” Large Diameter OTW PTA Catheter - Product Description 35
Table 45: 0.035” Next Generation Workhorse PTA Catheter - Product Status 35
Table 46: 0.035” Next Generation Workhorse PTA Catheter - Product Description 36
Table 47: Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview 37
Table 48: PTA Balloon Catheter - Above Knee - Product Status 37
Table 49: PTA Balloon Catheter - Above Knee - Product Description 38
Table 50: Glossary 60

1.2 List of Figures
Figure 1: Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Stage of Development 7
Figure 2: Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Territory 8
Figure 3: Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Regulatory Path 9
Figure 4: Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Estimated Approval Date 10
Figure 5: Percutaneous Transluminal Angioplasty Balloons - Ongoing Clinical Trials 11

【掲載企業】

Andramed GmbH
Arravasc Limited
Boston Scientific Corporation
Contego Medical, LLC
MicroPort Scientific Corporation
Occlutech International AB
QT Vascular Ltd.
SurModics, Inc.
Terumo Corporation

★調査レポート[世界の経皮的血管形成術用バルーン市場:医療機器パイプライン分析2016]販売に関する免責事項
★調査レポート[世界の経皮的血管形成術用バルーン市場:医療機器パイプライン分析2016]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆